Literature DB >> 27768225

Comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.

Dan Călugăru1, Mihai Călugăru1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27768225     DOI: 10.5301/ejo.5000898

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


× No keyword cloud information.
  1 in total

1.  Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema.

Authors:  Dan Călugăru; Mihai Călugăru
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-07       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.